Determinants of HIV Transmission Eric Hunter Emory Vaccine Center.

Slides:



Advertisements
Similar presentations
Nick Curry, MD, MPH Infectious Diseases Prevention Section
Advertisements

Design and Use of HIV-1 Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibody Responses David C. Montefiori, Ph.D. Laboratory.
Evoluzione genetica di HIV ed evoluzione clinica della malattia AIDS: due aspetti correlati? Carlo Federico Perno.
GENERAL AWARENESS ON HIV/AIDS Presented by: WeHELP In Association with its MEDICAL TEAM.
Utilizing a Non-Commercial Real- Time PCR to Detect HIV-1 RNA in HIV Antibody Negative Diagnostic Sera Submitted to The Maryland Public Health Laboratory.
Pediatric Diagnosis of HIV-1 Infection Using Dried Blood Spots Chin-Yih Ou, PhD NCHSTP/DHAP Centers for Disease Control and Prevention.
The role of immune responses in HIV-1 Infection Marylyn M. Addo, MD/PhD Partners AIDS Research Center Massachusetts General Hospital Harvard Medical School.
Primary HIV Infection: the CDC study Pragna Patel, MD MPH Medical Epidemiologist Behavioral and Clinical Surveillance Branch DHAP, CDC February 28, 2005.
Designing and Optimizing an Adenovirus Encoded VLP Vaccine against HIV Anne-Marie Andersson PhD Student, University of Copenhagen.
Analysis of Genetic Linkage of HIV from Couples Enrolled in the HPTN 052 Trial Susan H. Eshleman, MD/PhD HPTN Network Laboratory Johns Hopkins Univ. School.
CDC Investigations Relevant to Potential for Simian Foamy Virus Transmission by Transfusion Louisa Chapman, MD, MSPH OD, DASTLR, NCID, CDC & HIV and Retrovirology.
Identification of an informative and accurate region of the HCV genome for phylogenetic analyses Patrik Medstrand Clinical Virology.
HIV/AIDS as a Microcosm for the Study of Evolution.
Informatics Support for Vaccine Projects Using and extending the UCSC bioinformatics infrastructure.
Detection of XMRV/pMuLV Infections in Patients with Chronic Fatigue Syndrome and Healthy Blood Donors Shyh-Ching Lo, Ph.D., M.D. Division of Cellular and.
Weighing 17 years of evidence: Does hormonal contraception increase HIV acquisition risk among Zambian women in discordant couples? Kristin.
Materials and Methods Abstract Conclusions Introduction 1. Korber B, et al. Br Med Bull 2001; 58: Rambaut A, et al. Nat. Rev. Genet. 2004; 5:
Viruses.
Replication capacities of chimeric NL4-3 encoding gag-protease from recent HIV-1 isolates are significantly reduced compared to those derived from isolates.
HIV/AIDS Presented by Kunphen center for substance dependence and HIV/AIDS.
Detection of parvovirus B19 and novel human parvoviruses in high-risk individuals Ashleigh Manning 1, Kate Templeton 2, Ed. Gomperts 3, Peter Simmonds.
Figure 1 A Case Series of Discordant Laboratory Results with Statewide Rapid HIV Testing in New Jersey Eugene G Martin, PhD 1, Gratian Salaru, MD 1, Sindy.
Using Phylogenetic Analysis to Identify HIV Transmission Channels among Persons Newly Diagnosed with HIV-1 Infection in Los Angeles County, Kwa.
HIV-1 subtype C now accounts for approximately 50% of the estimated 33 million people living with HIV/AIDS and half of the 1-2 million new infections annually.
Autologous T-cell therapy based on a lentiviral vector expressing long antisense RNA targeted against HIV-1 env gene influences HIV replication and evolution.
Characteristics of transmitted viruses in acute and early HIV infection Eric Hunter IAC 2010.
Persistent low-level viremia despite clinically successful antiretroviral therapy appears correlated with more frequent resting CD4+ T cell Infection NM.
Phylogenetic Insight into HIV Transmission Networks in a Southeastern US Cohort Ann Dennis 1, Stéphane Hué 2, Christopher Hurt 1, Sonia Napravnik 1, Deenan.
HIV-1 evolution in response to immune selection pressures
The evolution of HIV Why is HIV fatal?. Lethal strains are favored, due to “Short sighted” evolution within hosts Transmission rate advantages.
From Genomic Sequence Data to Genotype: A Proposed Machine Learning Approach for Genotyping Hepatitis C Virus Genaro Hernandez Jr CMSC 601 Spring 2011.
RV 144: The Thai Phase III Trial and Development of a Globally-Effective, Multi-Clade HIV Vaccine HIV Vaccine: Quo Vadis AIDS July 2010 Dr. Merlin.
Partners in Prevention Jim Hughes in collaboration with, and many slides stolen from … Connie Celum Mary Campbell Jai Lingappa Gerry Myers Jim Mullins.
Figure 1: HIV-1 sequencing and linkage results for transmission pairs. 3 Month Seroconverters were not included as study endpoints, as seroconversion occurred.
Conclusions Results show that the mutation at the N-linked glycosylation site N276D has a distinct influence on sensitivity to the HJ16 CD4bs neutralizing.
Lecture 21 Case study: influenza virus and Case study: HIV/AIDS.
21th VHPB Meeting on “Prevention of viral hepatitis in Italy: lessons learnt and the way forward” Catania, 7-8 november 2002 Impact of HBV S-gene mutants.
West Nile Virus: Pathogenesis and Diagnostic Tools Maria Rios, PhD - Senior Staff Fellow Laboratory of Molecular Virology DETTD/OBRR/CBER/FDA WNV epidemic.
REASSORTMENT OF INFLUENZA VIRUS
Phenotypic properties influencing HIV-1 transmission fitness IAS Conference on HIV Pathogenesis, Treatment & Prevention Vancouver July 21 st 2015 Katja.
Patterns of selection for or against amino acid change among different CD4 T-cell count progressor groups Michael Pina, Salomon Garcia Journal Club Presentation.
HIV-1 & HIV : Robert Gallo: HTLV-1/ lymphocytes 1978: Robert Gallo: HTLV-1/ lymphocytes of leukemia patients of leukemia patients HTLV :
High Discordance in Plasma and Genital Tract HIV-1 Drug Resistance in Indian Women Failing First-line Therapy MOPDA0106 S. Saravanan, PhD Session Code:
Evolution of Couples Voluntary Counseling and Testing for HIV in Rwanda Etienne Karita, Sabin Nsanzimana, Felix Ndagije, Kristin Wall, Jeannine Mukamuyango,
Examining Genetic Similarity and Difference of the Three Progressor Groups at the First and Middle Visits Nicole Anguiano Bioinformatics Laboratory Loyola.
HIV Testing in Acute Care Settings Rich Rothman, MD, PhD, FACEP CDC, DHHS, OraSure Technologies, Abbott  Historical.
New Developments in HIV Kerri Howley Coordinator – The Green Room
HIV/AIDS Minnesota Department of Education HIV/AIDS Prevention Program.
CATEGORY: VACCINES & THERAPEUTICS HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK HIV-1 Vaccines © The copyright for this work resides.
Evolution and transmission in HIV Steve Paterson Review; Rambaut 2004 Nature Reviews Genetics 5: ‘The causes and consequences of HIV evolution’
Serologic markers and molecular epidemiology of HBV from an HIV infected cohort from Cameroon Tshifhiwa Magoro 1, Emmaculate Nongpang 2, Lufuno Mavhandu.
Viral evolution and adaption
Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960
The impact of treatment duration on defective and expanded identical HIV genomes in T cell subsets from peripheral blood and tissues Eunok Lee.
HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK
Department of Epidemiology
Differences in Demographic Profiles and Sexual Behaviors among Female Sex Workers (FSW) in Zambia´s Two Largest Cities Muyunda Mulenga1, Ruth Kanswe1,
Partners AIDS Research Center Massachusetts General Hospital
Within-host evolution of X4 HIV-1 in a rare transmission pair revealed by phylogenetic reconstruction of deep-sequence data Anh Q. Le, Jeremy Taylor, Winnie.
The HIV Genome Is A Busy Place
Viral Genetics.
Volume 127, Issue 3, Pages (September 2004)
Volume 127, Issue 3, Pages (September 2004)
Quasispecies tropism and compartmentalization in gut and peripheral blood during early and chronic phases of HIV-1 infection: possible correlation with.
Frequency and implications of HIV superinfection
HIV-Host Interactions: Implications for Vaccine Design
Evolution and transmission in HIV
Volume 15, Issue 6, Pages (December 2001)
Parallel evolution of influenza across multiple spatiotemporal scales
Volume 15, Issue 6, Pages (December 2001)
Presentation transcript:

Determinants of HIV Transmission Eric Hunter Emory Vaccine Center

Hypothesis An effective prophylactic vaccine against HIV-1 must protect against those viruses that initiate infection at the mucosal surface. These may be distinct from the bulk of the variants that have evolved to survive during their growth in the chronically infected host. What is the nature of these viruses and where do they come from?

Heterosexual transmission in HIV Discordant Couples HIV discordant couples represent a significant fraction of more than 50,000 couples tested in the capital cities of Zambia (20%) and Rwanda (12%). Despite counseling and condom provision, low levels of transmission still occur (7%/yr in Zambia, 3%/yr Rwanda). Approximately 80-85% of transmissions are epidemiologically linked (i.e. within the couple) allowing comparison of donor and recipient viruses.

Genetic bottleneck during transmission of HIV Transmission Diverse virus population in chronically infected “donor” Re-emergence of viral diversity

Characterization of transmitted viruses We report here today on the analysis of 21 transmission pairs from Zambia and Rwanda, where we have utilized a p24 ELISA assay to identify newly infected individuals who are antigen positive/antibody negative. To avoid resampling and in vitro recombination, we have used single genome amplification of env genes from both the transmitting partner (donor) and the newly infected partner (recipient).

Recipient Plasma Recipient PBMC Donor Plasma Donor PBMC An Extreme Genetic Bottleneck occurs during Transmission In this linked transmission pair the recipient virus is relatively homogeneous and originates from a single branch of the donor phylogenetic tree - thus a single genetic variant has established infection.

An Extreme Genetic Bottleneck occurs during MTF AND FTM Transmission In 18/19 Zambian subtype C transmission pairs this extreme genetic bottleneck was observed Recipient Donor

In 8/9 Rwandan and Zambian subtype-A transmission pairs examined to-date a similar severe bottle- neck has been observed following transmission. A similar genetic bottleneck is seen in Rwandan transmission pairs

The virus population in the acutely infected recipient is remarkably homogeneous 27/40 = 67% identical 11/40 - one base change 2/40 - two base changes Modeling of virus replication and evolution in the absence of selection would predict: 76% identical at 13 days 58% identical at 26 days 45% identical at 40 days to transmitted variant

Remarkable levels of homogeneity are observed even when full length genomes are amplified

Highlighter comparison of 0,2 and 6 month NFLG amplicons At the time of initial sample collection three genomes are identical and the bulk of the remaining genomes have a single nucleotide change However, the majority of these cluster within a potential Vpu CTL epitope, are non-synonymous changes and persist over 5 months - suggesting very early CTL escape and selection. Limited additional changes at 2 months PI, but a cluster of mutations in env at 6 months PI - suggesting antibody selection.

Homogeneity of recipient viruses in linked transmissions 26/28 recipient ‘quasispecies’ (17 sub-type C, 1 G, 1U and 9A) originate from a single branch of the chronically infected donor phylogenetic tree - arguing for an initiation of infection by a single virus/virus-infected cell. Recipient viruses exhibit very limited heterogeneity in both Env and Gag irrespective of whether they are amplified from p24+ve or p24-ve seroconvertors. In acutely infected recipients (virus positive, antibody negative), the homogeneous virus population is likely to represent the infecting virus genotype. Preliminary analyses of genital fluids do not support the hypothesis that the genetic bottleneck is a result of very limited viral genetic diversity in these tissues.

Where does the bottleneck originate In the donor? –through limited heterogeneity in the genital fluids –Unlikely - compartmentalization of genital fluid virus is observed but these enriched populations do not appear to be the source of the transmitted virus (D. Boeras - 16:45 this afternoon - Oral abstract session - Abstract # MOAA0302) In the recipient? –at the mucosal surface –selection during virus outgrowth

Heterogeneity in acutely infected individuals What happens if we examine heterogeneity in unlinked transmissions in the same discordant couple cohort? Studies of Overbaugh and colleagues with Kenyan sex workers (Long et al., 2000 & pers. comm.), and Swanstrom and colleagues in STD clinic participants (Ritola et al., 2004) have shown that transmission of multiple variants can occur in up to half of the cases examined. Is linked transmission in discordant couples inherently different -low frequency of STDs -single partner.

4 cases of transmission of a single donor variant 3 cases of transmission of multiple donor variants (from a single source) Establishment of infection in unlinked transmissions can involve a less severe genetic bottleneck

Multiple variants can be confirmed in the Highlighter analysis

Heterogeneity in the unlinked recipient is linked to evidence of inflammatory genital infections

Heterogeneity in 5/42 newly infected recipients is linked to inflammatory or ulcerative infections

Conclusions The presence of multiple genetic variants in newly infected recipients indicates that the extreme bottleneck we have observed with linked transmissions most likely occurs at the genital mucosa rather than during virus outgrowth. The extremity of the genetic bottleneck appears to be modulated by genital infections: –These could provide an inflammatory environment with increased numbers of target cells. –They could result in breaks in the genital mucosa allowing access to underlying target cells.

Conclusions It seems likely that when the mucosal surface is intact that a single genetic variant establishes infection following transmission. Whereas in the presence of genital infections, or other situations that increase accessibility to target cells in the mucosa, multiple variants can be transmitted. However, because 85% of transmissions in discordant couples are linked and primarily occur in the absence of STDs (Trask et al., 2001; Fideli et al., 2001), there does not appear to be a requirement for disruption of the mucosal barrier for transmission to occur.

Acknowledgements Emory University Hunter Lab Debi Boeras, Ph.D. Paulina Hawkins Rich Haaland, Ph.D. Colleen Kraft, M.D. Ling Yue, M.D. Paul Farmer, Ph.D. Derdeyn Lab Cynthia Derdeyn, Ph.D. Los Alamos National Laboratory Bette Korber, Ph.D. Karina Yusim LANL Team Emory/RZHRG cohorts The Staff and Participants Susan Allen, M.D., MPH Joseph Mulenga, M.D. Lawrence Elwyn Chomba, M.D. Olivier Manigart, Ph.D. Etienne Karita, M.D. Kayitesi Kayitenkore M.D. Amanda Tichacek, MPH Funding: IAVI (Allen) NIH R01 AI (Hunter/Derdeyn) NIH R01 AI (Derdeyn) Gates Grand Challenge (Shaw) NIH P30 AI Emory Center for AIDS Research Univ. Alabama at Birmingham Shaw/Hahn Lab Jesus Salazar, Ph.D. Beatrice Hahn, M.D. George Shaw, M.D., Ph.D.

The genetic bottleneck is identical if instead we look at the Gag gene in linked transmissions As with our observations for env we find limited heterogeneity in gag and each recipient sequence emanates from a single branch of the donor tree.

Donor - GFRecipient - Blood Could the genetic bottleneck be the result of limited diversity in genital fluids?

Compartmentalization of viral variants in the genital fluids is not the origin of the extreme genetic bottleneck Recipient Plasma Recipient PBMC Donor Plasma Donor PBMC Donor Genital Fluids